CSIS Conference on the Strategic Power of Vaccines

  • Friday, Dec 9, 2011
  • The second CSIS High-Level Forum on U.S. Leadership in Global Health placed a focus on vaccines as instruments of U.S. global leadership in pursuit of security and economic interests at home and abroad, in close enduring partnerships with corporations, foundations, multilateral organizations, and other countries.

    This conference grows out of the remarkable surge of interest in vaccines in public health efforts worldwide. Last year, the Bill & Melinda Gates Foundation committed $10 billion to help research, develop, and deliver vaccines over the next ten years, which it christened the Decade of Vaccines. Recent analyses in The Lancet, Nature, Health Affairs, and elsewhere have portrayed vaccines as a “best buy,” a cost-effective global health tool in a tough fiscal environment. In June, at its first pledging conference, the GAVI Alliance received $4.3 billion in commitments from governments and private donors, surpassing its $3.7 billion target.

    Along with this growing awareness of the value of vaccines, there has arisen a heightened grasp of the complexities of global immunization efforts. There is uncertainty about continued funding and sustainable programs, shoring up public trust in immunization, bringing current campaigns to a successful conclusion, creating the market conditions for the research and development of new vaccines, and guaranteeing their availability and delivery to those most in need, particularly in unstable and insecure environments.

    Featuring keynote speaches from:

    Rajiv Shah
    U.S. Agency for International Development

    Anthony Fauci
    National Institute of Allergy and Infectious Diseases, NIH

    And panel discussions including:

    Stephen Cochi, CDC
    Helen Evans,
    GAVI Alliance
    Admiral William Fallon
    Markus Geisser,
    International Committee of the Red Cross
    Julie Gerberding,
    Merck Vaccines
    Amanda Glassman,
    Center for Global Development
    John Hamre,
    Orin Levine,
    Johns Hopkins Bloomberg School of Public Health
    Margaret McGlynn,
    International AIDS Vaccine Initiative
    J. Stephen Morrison,
    Regina Rabinovich,
    Bill & Melinda Gates Foundation
    Anne Schuchat,
    Eric Schwartz,
    U. of Minnesota Humphrey School of Public Affairs


Find More On:

Global Health